CELL-DYN Retic Plus Control Level I & II

Hazard statements (CLP)

H317, H334

Code

Statements

H317

May cause an allergic skin reaction

SECTION 2: Hazards identification

Directive 1999/45/EC: Classification of the substance or mixture

Hazard pictograms

GHS08

Signal word

Danger

Hazardous Ingredients

Proprietary Ingredient - Cell Stabilizing Components (biological salts, anticoagulants, osmotic stabilizers) (Contd. on page 2) GB Trade name: CELL-DYN Retic Plus Control Level I & II (Contd. of page 1)

Hazard statements

H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. H317 May cause an allergic skin reaction.

Precautionary statements

P285 In case of inadequate ventilation wear respiratory protection. P261 Avoid breathing mist / vapours / spray. P280 Wear protective gloves / protective clothing / eye protection. P272 Contaminated work clothing should not be allowed out of the workplace. P342+P311 If experiencing respiratory symptoms: Call a POISON CENTER or doctor/physician. P302+P352 IF ON SKIN: Wash with plenty of water. P304+P341 IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. P333+P313 If skin irritation or rash occurs: Get medical advice/attention. P363 Wash contaminated clothing before reuse. P501 This material and its container must be disposed of in a safe way.

Additional information

Potentially infectious

2.3 Other hazards

This preparation contains human-sourced components. No known test method can offer complete assurance that products derived from human sources will not transmit infection. Therefore, all human-sourced materials should be considered potentially infectious.

PBT Substances

Not applicable

vPvB Substances

Not applicable *

2.1 Classification of the substance or mixture

· Classification according to Regulation (EC) No 1272/2008 GHS08 health hazard Resp. Sens. 1 H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. GHS07 Skin Sens. 1 H317 May cause an allergic skin reaction. · Classification according to Directive 67/548/EEC or Directive 1999/45/EC Xn; Sensitising R42/43: May cause sensitisation by inhalation and skin contact. · Classification system: The classification is in alignment with current EC (European Community) Directives. It incorporates information from technical literature and information provided by supplier companies. · Label elements · Labelling according to Regulation (EC) No 1272/2008 The product is classified and labelled according to the CLP regulation. · Hazard pictograms GHS08 · Signal word Danger · Hazard-determining components of labelling: Proprietary Ingredient - Cell Stabilizing Components (biological salts, anticoagulants, osmotic stabilizers) (Contd. on page 2)